ProText Mobility, Inc. Stock Price - TXTM

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Protext Mobility, Inc. (PL) TXTM Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.0001 -5.88% 0.0016 0.0019 0.0014 0.0018 0.0017 15:46:58
Bid Price Ask Price Spread Spread % News
0.0015 0.0016 0.0001 6.25% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
149 57,475,713 $ 0.0016 $ 92.36k 153.22M - - -
Last Trade Time Type Quantity Stock Price Currency
15:46:58 100,000 $0.00 USD

Protext Mobility, Inc. (PL) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.11M 1.95B $ -1.45M - -2.15 1.72B
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
200k 0.01% $ - 0.00% - -

more financials information »

Protext Mobility, Inc. (PL) News

Historical TXTM Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0020.00250.00120.000045M105M80M-0.0004-20.00%
1 Month0.00060.00560.00050.000045M576M216M0.001166.67%
3 Months0.00010.00560.00010.00000598M179M0.00151,500.00%
6 Months0.0010.00560.0000010.00000598M115M0.000660.00%
1 Year0.00010.00560.0000010.00000598M58M0.00151,500.00%
3 Years0.0490.300.0000010.00000598M20M-0.0474-96.73%
5 Years0.0070.300.0000010.00000598M16M-0.0054-77.14%

Protext Mobility, Inc. (PL) Description

Protext Mobility, through its acquisition of Plandai Biotechnology South Africa (pty) Ltd, is actively engaged in the research and clinical testing of bioceutical productsall natural ingredients formulated for pharmaceutical applications and processed under pharma-grade conditions. Phytofare is a highly bioavailable extract produced from live green tea leaves. Our initial product, Phytofare Catechin Complex, has been clinically proven to have 10 times greater bioavailability over generic catechin extracts. What this means is that Phytofare can deliver a therapeutic level of catechins to the system where they remain active for over 24 hours. The Company has a worldwide exclusive license to develop Phytofare in botanical drug applications.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.